Aristidis Moustakas focuses on SMAD, Transforming growth factor beta, Cell biology, Transcription factor and Signal transduction. His work deals with themes such as TGF beta signaling pathway, Cancer research and Kinase, which intersect with SMAD. His biological study spans a wide range of topics, including Epithelial–mesenchymal transition and Immunology.
His work in Transforming growth factor beta covers topics such as Cellular differentiation which are related to areas like Bone morphogenetic protein. His studies examine the connections between Cell biology and genetics, as well as such issues in Ubiquitin ligase, with regards to Tissue homeostasis. Aristidis Moustakas interconnects Platelet-derived growth factor receptor, Phosphorylation, Regulation of gene expression, Adherens junction and Mesenchymal–epithelial transition in the investigation of issues within Signal transduction.
Cell biology, SMAD, Transforming growth factor, Signal transduction and Cancer research are his primary areas of study. He is interested in Transforming growth factor beta, which is a branch of Cell biology. His studies deal with areas such as TGF beta signaling pathway, Molecular biology, Transcription factor and Kinase as well as SMAD.
As part of the same scientific family, he usually focuses on Transforming growth factor, concentrating on Stromal cell and intersecting with Extracellular matrix. His Signal transduction study incorporates themes from R-SMAD, Downregulation and upregulation and Protein kinase A, Phosphorylation. His Cancer research research is multidisciplinary, relying on both Epithelial–mesenchymal transition, Cancer, Metastasis, Cell growth and Immunology.
The scientist’s investigation covers issues in Cell biology, Transforming growth factor, Cancer research, Signal transduction and SMAD. His Cell biology study integrates concerns from other disciplines, such as Epithelial–mesenchymal transition and Bone morphogenetic protein, Gene, Cellular differentiation, Transcription factor. His Transforming growth factor study combines topics in areas such as Autocrine signalling, Extracellular, Crosstalk, Molecular biology and Gene isoform.
His work carried out in the field of Cancer research brings together such families of science as Carcinogenesis, Fibroblast, Metastasis and Immunology. Aristidis Moustakas has included themes like Cell surface receptor and Recombinant DNA in his Signal transduction study. His SMAD research integrates issues from Cell signaling, Tissue homeostasis, Kinase and WNT3A.
His primary areas of investigation include Cell biology, Transforming growth factor, Epithelial–mesenchymal transition, Cancer research and Signal transduction. He is interested in SMAD, which is a field of Cell biology. His research investigates the connection between Transforming growth factor and topics such as Crosstalk that intersect with issues in HCCS.
His study in Epithelial–mesenchymal transition is interdisciplinary in nature, drawing from both Serglycin, PI3K/AKT/mTOR pathway, Cellular differentiation and Pathology. Aristidis Moustakas combines subjects such as Extracellular matrix, Metastasis and Immunology with his study of Cancer research. In general Signal transduction, his work in Transforming growth factor beta is often linked to Janus kinase 1 and Cyclin-dependent kinase 9 linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Non-Smad TGF-β signals
Aristidis Moustakas;Carl-Henrik Heldin.
Journal of Cell Science (2005)
Smad regulation in TGF-beta signal transduction.
Aristidis Moustakas;Serhiy Souchelnytskyi;Carl-Henrik Heldin.
Journal of Cell Science (2001)
The regulation of TGFβ signal transduction
Aristidis Moustakas;Carl-Henrik Heldin.
Development (2009)
Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression
Aristidis Moustakas;Carl Henrik Heldin.
Cancer Science (2007)
Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.
Carl-Henrik Heldin;Maréne Landström;Aristidis Moustakas.
Current Opinion in Cell Biology (2009)
TGF-β and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition
Ulrich Valcourt;Marcin Kowanetz;Hideki Niimi;Carl-Henrik Heldin.
Molecular Biology of the Cell (2005)
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Katerina Pardali;Aristidis Moustakas.
Biochimica et Biophysica Acta (2007)
A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition.
Theresa Vincent;Theresa Vincent;Etienne P. A. Neve;Etienne P. A. Neve;Jill R. Johnson;Alexander Kukalev.
Nature Cell Biology (2009)
Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.
Aristidis Moustakas;Katerina Pardali;Annamaria Gaal;Carl Henrik Heldin.
Immunology Letters (2002)
Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
Sylvie Thuault;Ulrich Valcourt;Maj Petersen;Guidalberto Manfioletti.
Journal of Cell Biology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Uppsala University
University of Tokyo
Leiden University Medical Center
University of Crete
Uppsala University
Uppsala University
University of Barcelona
University of Patras
Uppsala University
University of Patras
University of Maryland, College Park
University of California, Los Angeles
University of Maryland, College Park
COMSATS University Islamabad
University of Lille
Yale University
South China University of Technology
Greifswald University Hospital
University of Pennsylvania
Ghent University
University of Bergen
Johns Hopkins University School of Medicine
Haukeland University Hospital
National Institutes of Health
Memorial Sloan Kettering Cancer Center
University of Bristol